Breaking News Story
The Trump administration’s recent decision to end a subsidy for Medicare prescription drug plans has sparked widespread concern among America’s most vulnerable populations—particularly seniors living on fixed incomes. As inflation and healthcare costs continue to rise under the current economic climate, many aging Americans now face the harsh reality of increased out-of-pocket expenses for essential medications. The subsidy, which historically helped offset the cost of prescription drugs for seniors enrolled in Medicare Part D, is being phased out as part of the administration’s broader healthcare policy shifts. While proponents argue that the move aims to streamline federal spending and reduce












